A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
NCT07489885
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Psoriasis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- InventisBio Co., Ltd
- Last updated on ClinicalTrials.gov
- July 9, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- Study Center · Birmingham, AL
California · 1
- Study Center · Chula Vista, CA
Texas · 1
- Study Center · San Antonio, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.